Epysqli
NDC Package 71202-010-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Epysqli is a . Marketed by Samsung Bioepis Co., Ltd., this product is identified by NDC 71202-010 and is authorized under FDA application BLA761340.

Identification & Billing

NDC Package Code
71202-010-01
Package Description
1 VIAL, SINGLE-DOSE in 1 CARTON / 30 mL in 1 VIAL, SINGLE-DOSE (71202-010-07)
Product Code
71202-010
11-Digit Billing Format
71202001001

Clinical Specifications

Proprietary Name
Epysqli
Dosage Form
-

Regulatory & Marketing

Labeler Name
Samsung Bioepis Co., Ltd.
FDA Application #
BLA761340
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
03-01-2025
End Marketing Date
03-01-2025
Listing Expiration
03-01-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71202-010-01 identifies a specific commercial package of 1 vial, single-dose in 1 carton / 30 ml in 1 vial, single-dose (71202-010-07) of Epysqli, labeled by Samsung Bioepis Co., Ltd.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Samsung Bioepis Co., Ltd. on March 01, 2025. The current certification is valid through March 01, 2025.

How is this Samsung Bioepis Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71202001001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71202-010-01
11-Digit CMS (5-4-2)
71202-0010-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.